Clinical Trial Update: Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating losartan for airway mucociliary dysfunction in COPD and chronic bronchitis was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: University of Miami | Conditions: COPD, Chronic Bronchitis | Phase 4 | Status: TERMINATED | Results posted: 2020-08-20